National Comprehensive Cancer Network

Research Institution
Favicons?domain=wwwPR Newswire | October 19, 2009

Updated NCCN Guidelines for AML Include Risk Stratification to Assist in Treatment Selection

FORT WASHINGTON, Pa., Oct. 19 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) recently made updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Acute Myeloid Leukemia, a cancer that starts inside...

In this article: National Comprehensive Cancer Network, Cancer, Leukemia, Acute myeloid leukemia, Clofarabine, Decitabine, Acute promyelocytic leukemia, 5-azacytidine, Rare disease, and Genzyme Corporation

Connections-toggle
Filter by
or